BioSpace News Archive

Fabry disease is a rare, X-linked inherited disease that results from abnormal deposits of a fatty substance in blood vessels.

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

Sinopharm, a Chinese biopharmaceutical company controlled by the state, announced that its COVID-19 vaccine candidate had an efficacy rate of 79% based on interim analysis of Phase III trials.

Operation Warp Speed succeeded on the development component but is failing in the early stages of distribution. Here’s everything you need to know about it.

Keeping in mind that COVID-19 has dominated the news cycle, here are the top 10 stories of 2020 in no particular order.

A great deal remains unknown about the SARS-CoV-2 virus, its mutations, transmissibility and long-term effects. Here’s what we do know.

Overnight, U.K. health authorities authorized the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use.

AIDS Healthcare Foundation welcomed and praised an advisory opinion issued earlier by the Office of the General Counsel for the United States Health and Human Services Department which concluded that drug manufacturers are required to deliver discounts under the 340B Drug Pricing Program on covered outpatient drugs when contract pharmacies are acting as agents of 340B covered entities.

Mosaic ImmunoEngineering Inc., (the “Company” or “Mosaic”) (OTC PINK:PTSCD), a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases, announced today that The Financial Industry Regulatory Authority, Inc., (FINRA), has approved a change in the Company’s stock symbol trading on the OTC Markets Pink.

The FDA is alerting pet owners and veterinary professionals about certain Sportmix pet food products manufactured by Midwestern Pet Foods, Inc. that may contain potentially fatal levels of aflatoxin.